WILL TRANSCUTANEOUS AURICULAR VAGAL NERVE STIMULATION ON MOTOR AND COGNATIVE PERFORMANC WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER EFFECTIVE

EFFECT OF TRANSCUTANEOUS AURICULAR VAGAL NERVE STIMULATION AND BEHAVIOURAL PARENT TRAINING ON MOTOR AND COGNITIVE PERFORMANCE WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER: A RANDOMIZED CONTROLLED TRIAL - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/066161

Enrollment

Registered

2024-04-23

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type

Interventions

Intervention1: Transcutaneous auricular vagal nerve stimulation (taVNS): The duration of the intervention is 4 weeks. Position of child- sitting/supine Therapist position- beside the patient Method-

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children with mild & moderate ADHD. 2. Children with inattentive & hyperactive impulsive. 3. Age group- 6-17years 4. Both genders 5. Children who are able to actively participate in a rehabilitation program, including engagement in physical activities

Exclusion criteria

Exclusion criteria: 1. Recent head injury. 2. Any operative neurological disorder. 3. Musculoskeletal disorder. 4. Multiple gestations. 5. Severe ADHD.

Design outcomes

Primary

Measure	Time frame
Vanderbilt ADHD Diagnostic Parent Rating ScaleTimepoint: baseline data will be taken and data will be analyzed at end of the treatment	—

Secondary

Measure	Time frame
. SNAP-IV rating scale 2.Child behaviour checklist scoring scale. Timepoint: baseline data will be taken and data will be analyzed at end of the treatment	—

Countries

India

Contacts

Public ContactRaghumahanti Raghuveer

Ravi Nair Physiotherapy college

raghuneuro@yahoo.com8126506769

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026